179 related articles for article (PubMed ID: 21457434)
1. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.
Khaliq S; Jahan S; Hassan S
Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434
[TBL] [Abstract][Full Text] [Related]
2. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions: modeling the hepatitis C virus ion channel p7.
Patargias G; Zitzmann N; Dwek R; Fischer WB
J Med Chem; 2006 Jan; 49(2):648-55. PubMed ID: 16420050
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.
Jones CT; Murray CL; Eastman DK; Tassello J; Rice CM
J Virol; 2007 Aug; 81(16):8374-83. PubMed ID: 17537845
[TBL] [Abstract][Full Text] [Related]
5. Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication.
Premkumar A; Dong X; Haqshenas G; Gage PW; Gowans EJ
Antivir Ther; 2006; 11(3):289-95. PubMed ID: 16759044
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HCV p7 as a therapeutic target.
Griffin S
Curr Opin Investig Drugs; 2010 Feb; 11(2):175-81. PubMed ID: 20112167
[TBL] [Abstract][Full Text] [Related]
7. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional analysis of the HCV p7 protein.
Saint N; Montserret R; Chipot C; Penin F
Methods Mol Biol; 2009; 510():125-43. PubMed ID: 19009258
[TBL] [Abstract][Full Text] [Related]
9. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.
Sakai A; Claire MS; Faulk K; Govindarajan S; Emerson SU; Purcell RH; Bukh J
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11646-51. PubMed ID: 14504405
[TBL] [Abstract][Full Text] [Related]
10. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
Mihm U; Grigorian N; Welsch C; Herrmann E; Kronenberger B; Teuber G; von Wagner M; Hofmann WP; Albrecht M; Lengauer T; Zeuzem S; Sarrazin C
Antivir Ther; 2006; 11(4):507-19. PubMed ID: 16856625
[TBL] [Abstract][Full Text] [Related]
11. Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
Walter S; Bollenbach A; Doerrbecker J; Pfaender S; Brown RJP; Vieyres G; Scott C; Foster R; Kumar A; Zitzmann N; Griffin S; Penin F; Pietschmann T; Steinmann E
J Virol; 2016 May; 90(10):5075-5089. PubMed ID: 26962224
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus p7 mediates membrane-to-membrane adhesion.
Lee GY; Lee S; Lee HR; Yoo YD
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1096-1101. PubMed ID: 27320856
[TBL] [Abstract][Full Text] [Related]
13. Evidence suggesting that HCV p7 protects E2 glycoprotein from premature degradation during virus production.
Atoom AM; Jones DM; Russell RS
Virus Res; 2013 Sep; 176(1-2):199-210. PubMed ID: 23816605
[TBL] [Abstract][Full Text] [Related]
14. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
[TBL] [Abstract][Full Text] [Related]
15. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
Wozniak AL; Griffin S; Rowlands D; Harris M; Yi M; Lemon SM; Weinman SA
PLoS Pathog; 2010 Sep; 6(9):e1001087. PubMed ID: 20824094
[TBL] [Abstract][Full Text] [Related]
16. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
17. NMR structure and ion channel activity of the p7 protein from hepatitis C virus.
Montserret R; Saint N; Vanbelle C; Salvay AG; Simorre JP; Ebel C; Sapay N; Renisio JG; Böckmann A; Steinmann E; Pietschmann T; Dubuisson J; Chipot C; Penin F
J Biol Chem; 2010 Oct; 285(41):31446-61. PubMed ID: 20667830
[TBL] [Abstract][Full Text] [Related]
18. Understanding the molecular targets for new therapeutical agents in hepatitis c infection.
Vagu C; Sultana C; Ruţă S
Roum Arch Microbiol Immunol; 2013; 72(1):5-24. PubMed ID: 23947011
[TBL] [Abstract][Full Text] [Related]
19. Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.
StGelais C; Foster TL; Verow M; Atkins E; Fishwick CW; Rowlands D; Harris M; Griffin S
J Virol; 2009 Aug; 83(16):7970-81. PubMed ID: 19493992
[TBL] [Abstract][Full Text] [Related]
20. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
